Major Depressive Disorder Excellence Forum

Major Depressive Disorder

Excellence Forum

Videos

Addressing Depression Symptoms With a Comprehensive Approach

08/06/2023

With Ahmed Baig, MD

Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.

Ahmed Baig, MD, Chief Medical...

08/06/2023

Psych Congress Network

Videos

Novel Treatments for MDD and TRD

08/03/2023

With Ahmed Baig, MD

Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.

Ahmed Baig, MD, Chief Medical...

08/03/2023

Psych Congress Network

Susan Montgomery, DNP, FNP-BC, and Lauren Sharp, FNP

Videos

Routine Depression Screening Increases Identification, Diagnosis, and Management: Part 2

08/01/2023

Susan Mongomery, DNP, FNP-BC, and Lauren Sharp, FNP, share more about findings from their study “Improving Screening for Major Depressive Disorder."

Susan Mongomery, DNP, FNP-BC,...

08/01/2023

Psych Congress Network

Why are clinicians wary of antipsychotic use in MDD treatment?

Expert Insights Quiz

Why do clinicians tend to underuse antipsychotics in the treatment of MDD?

07/27/2023

With Craig Chepke, MD, DFAPA

Time for a pop quiz!

07/27/2023

Psych Congress Network

Videos

Why Antipsychotics Are Underutilized for Major Depressive Disorder (MDD)

07/25/2023

Featuring Craig Chepke, MD, DFAPA

Featuring Craig Chepke, MD, DFAPA ...

Craig Chepke, MD, DFAPA, shares why he thinks clinicians do not use antipsychotics for MDD treatment as much as they could.

Craig Chepke, MD, DFAPA, shares...

07/25/2023

Psych Congress Network

Pop quiz written on a blackboard with white chalk

Expert Insights Quiz

How can clinicians optimize treatment with subcutaneous racemic ketamine for TRD?

07/25/2023

Put your psychiatry knowledge to the test with this quiz!

Put your psychiatry knowledge to...

07/25/2023

Psych Congress Network

Expert Insights Quiz

How many patients accepted depression treatment following diagnosis?

07/22/2023

Test your knowledge!

07/22/2023

Psych Congress Network

Q&As

Ketamine Treatment in TRD Should Last 4 Weeks or More for Antidepressant Benefit

07/21/2023

Featuring Colleen Loo, MBBS, FRANZCP, MD

Featuring Colleen Loo, MBBS, FRANZCP,...

Colleen Loo, MBBS, FRANZCP, MD, lead researcher of a groundbreaking study on the use of subcutaneous racemic ketamine for TRD, shares the rationale behind the study, its major findings, practical implications, and more.

Colleen Loo, MBBS, FRANZCP, MD,...

07/21/2023

Psych Congress Network

Videos

Routine Depression Screening Increases Identification, Diagnosis, and Management: Part 1

07/21/2023

Susan Mongomery, DNP, FNP-BC, and Lauren Sharp, FNP, discuss findings from their study “Improving Screening for Major Depressive Disorder."

Susan Mongomery, DNP, FNP-BC,...

07/21/2023

Psych Congress Network

Expert Insights Quiz

Who saw the most improvement in depressive symptoms after physical activity?

07/17/2023

Was it children older or younger than 13 years?

Was it children older or younger...

07/17/2023

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Major Depressive Disorder Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products